EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile

Marcelo A S de Toledo, Xuhuang Fu iD, Tiago Maié iD, Eva M Buhl, Katrin Götz, Susanne Schmitz, Anne Kaiser, Peter Boor iD, Till Braunschweig iD, Nicolas Chatain iD, Ivan G Costa, Tim H Brümmendorf iD und 2 weitere

International Journal of Molecular Sciences · 09.03.2023 · 24 (6) · 5275

DOI: 10.3390/ijms24065275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.03.2023. Verfasst von Marcelo A S de Toledo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, 52074 Aachen, Germany. Hauptthemen laut MEDLINE: Mastocytosis, Systemic, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, China Scholarship Council, CAPES-Alexander von Humboldt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mast cells (MCs) represent a population of hematopoietic cells with a key role in innate and adaptive immunity and are well known for their detrimental role in allergic responses. Yet, MCs occur in low abundance, which hampers their detailed molecular analysis. Here, we capitalized on the potential of induced pluripotent stem (iPS) cells to give rise to all cells in the body and established a novel and robust protocol for human iPS cell differentiation toward MCs. Relying on a panel of systemic mastocytosis (SM) patient-specific iPS cell lines carrying the KIT D816V mutation, we generated functional MCs that recapitulate SM disease features: increased number of MCs, abnormal maturation kinetics and activated phenotype, CD25 and CD30 surface expression and a transcriptional signature characterized by upregulated expression of innate and inflammatory response genes. Therefore, human iPS cell-derived MCs are a reliable, inexhaustible, and close-to-human tool for disease modeling and pharmacological screening to explore novel MC therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastocytosis, SystemicInduced Pluripotent Stem CellsHumansMast CellsPhenotypeProto-Oncogene Proteins c-kitMutation

Stichwörter der Autor:innen

KIT D816VRNA-seqdisease modelingiPS cell differentiation protocolinduced pluripotent stem cellmast cellsystemic mastocytosis

Substanzen

Proto-Oncogene Proteins c-kit

Autor:innen und Institutionen

  • Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, 52074 Aachen, Germany.
  • Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany.
  • Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical School, 52074 Aachen, Germany.
  • Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), 52074 Aachen, Germany.
  • Institute for Computational Genomics, RWTH Aachen University Medical School, 52074 Aachen, Germany.
  • Institute for Pathology, Electron Microscopy Facility, RWTH Aachen University Medical School, 52074 Aachen, Germany.

ORCID-Profile: Xuhuang Fu, Tiago Maié, Peter Boor, Till Braunschweig, Nicolas Chatain, Tim H Brümmendorf, Steffen Koschmieder, Martin Zenke

Förderung

  • Deutsche Forschungsgemeinschaft
  • China Scholarship Council
  • CAPES-Alexander von Humboldt
  • RWTH Aachen University Faculty of Medicine START grant
  • CAPES–Alexander von Humboldt
  • RWTH Aachen University Faculty of Medicine START
  • Interdisciplinary Center for Clinical Research

Zitieren

APA

de Toledo, M. A. S., Fu, X., Maié, T., Buhl, E. M., Götz, K., Schmitz, S., Kaiser, A., Boor, P., Braunschweig, T., Chatain, N., Costa, I. G., Brümmendorf, T. H., Koschmieder, S., & Zenke, M. (2023). KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile. International Journal of Molecular Sciences, 24(6), 5275. https://doi.org/10.3390/ijms24065275

Vancouver

de Toledo MAS, Fu X, Maié T, Buhl EM, Götz K, Schmitz S, et al. KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile. International Journal of Molecular Sciences. 2023;24(6):5275. doi:10.3390/ijms24065275

BibTeX
@article{deToledo2023,
  author = {de Toledo, Marcelo A S and Fu, Xuhuang and Maié, Tiago and Buhl, Eva M and Götz, Katrin and Schmitz, Susanne and Kaiser, Anne and Boor, Peter and Braunschweig, Till and Chatain, Nicolas and Costa, Ivan G and Brümmendorf, Tim H and Koschmieder, Steffen and Zenke, Martin},
  title = {KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {5275},
  doi = {10.3390/ijms24065275}
}
Kostenlos starten →